Psychosurgery

Abstract

Psychosurgery is a form of psychiatric somatic therapy that treats severe mental disorder by deliberately operating on the brain; MeSH catalogues it as descriptor D011612. It began in 1935 with the prefrontal leucotomy of António Egas Moniz, whose 1949 Nobel Prize crowned a decade in which Walter Freeman popularised the lobotomy and tens of thousands were operated on before antipsychotic drugs and an ethical reckoning ended the era. Modern psychosurgery is a narrow, regulated practice built on stereotactic precision: focal ablative lesions such as anterior capsulotomy, and reversible deep brain stimulation for treatment-resistant obsessive-compulsive disorder and depression. This article traces that history, distinguishes the crude lobotomy from its focal successors, and weighs the controlled evidence for the modern procedures.

Keywords: psychosurgery, lobotomy, deep brain stimulation, stereotactic surgery

What Psychosurgery Is

Psychosurgery is the treatment of a psychiatric disorder by an operation that deliberately alters brain tissue — historically by severing or destroying it, and in the modern era also by implanting electrodes that modulate its activity. It is distinguished from neurosurgery for a structural lesion such as a tumour or an epileptic focus: the target of psychosurgery is not diseased tissue but the neural substrate of a mental symptom, and the aim is a change in mood, thought, or behaviour rather than the removal of a physical abnormality (#ref-feldman-goodrich-2001). This is what places it, uneasily, among the somatic treatments for mental illness rather than among general neurosurgical procedures.

MeSH files the descriptor (D011612) in two trees at once, and the double placement captures the field's divided identity. It sits under psychiatric somatic therapies, grouping it with the physical treatments of mental disorder alongside electroconvulsive therapy and psychopharmacology, and also under neurosurgical procedures in the surgical tree. As with any MeSH placement, the classification is an indexing convention for cataloguing the literature, not a judgement on the method (#ref-mashour-2005).

The word carries a heavy history, because for most of the twentieth century psychosurgery meant the lobotomy, and the lobotomy became a byword for medical overreach. Understanding the field requires separating two things that share a name: the crude, wholesale destruction of frontal-lobe connections practised from the 1930s to the 1950s, and the focal, imaging-guided, often reversible interventions that a small number of specialised centres offer today. The two are related only by lineage; in precision, evidence, and regulation they are nearly opposite (#ref-feldman-goodrich-2001).

The Lobotomy Era

Modern psychosurgery is conventionally dated to 1935, when the Portuguese neurologist António Egas Moniz, with the surgeon Almeida Lima, performed the first prefrontal leucotomy — cutting the white-matter tracts connecting the prefrontal cortex to deeper structures, on the theory that fixed pathological patterns of thought were sustained by these connections and could be broken by severing them (#ref-tan-yip-2014). Moniz reported improvement in agitated and depressed patients, and the operation spread rapidly through a psychiatry that had almost no effective treatment for severe institutional illness. In 1949 Moniz was awarded the Nobel Prize in Physiology or Medicine for the leucotomy, an endorsement that accelerated the procedure's worldwide adoption (#ref-gross-schafer-2011).

In the United States the operation was taken up and transformed by the neurologist Walter Freeman, who with the neurosurgeon James Watts developed a standardised prefrontal lobotomy and then, seeking a procedure simple enough to perform outside an operating theatre, the transorbital lobotomy — an instrument resembling an ice pick driven through the bony orbit above the eye and swept to sever frontal connections (#ref-pressman-1998). Freeman performed or supervised thousands of these operations, many in state psychiatric hospitals on patients with schizophrenia and other chronic conditions, and often without a surgeon present. The transorbital technique made the lobotomy fast, cheap, and portable, which is precisely why it was applied on a scale that later generations found indefensible.

The clinical rationale was thin from the start. The leucotomy rested on a speculative account of frontal-lobe function, outcomes were assessed by the operators themselves without controls, and the “improvement” that justified the surgery frequently amounted to a blunting of emotion and initiative that made difficult patients more manageable (#ref-feldman-goodrich-2001). The harms — apathy, disinhibition, cognitive loss, seizures, and death — were substantial and, because the tissue was destroyed, permanent. The era stands as the paradigm case of a treatment adopted far ahead of any evidence that it worked.

Decline and the Ethical Reckoning

Two forces ended the lobotomy era. The first was pharmacological: the introduction of chlorpromazine and the antipsychotic drugs in the 1950s gave psychiatry a treatment for psychosis that was effective, adjustable, and reversible, removing the desperation that had made irreversible brain surgery seem reasonable (#ref-mashour-2005). The second was ethical and cultural. As the scale of the lobotomy programme became visible, and as accounts of its human cost accumulated, the operation came to symbolise the abuse of psychiatric authority, and it was progressively abandoned, restricted, and in some jurisdictions banned outright (#ref-pressman-1998).

The reckoning extended to Moniz's Nobel Prize, which became one of the most contested awards in the history of the prize. Later historical and ethical reanalysis argued that the leucotomy had been honoured on the strength of uncontrolled reports and enthusiastic advocacy rather than sound evidence, and that the award had lent scientific legitimacy to a harmful procedure (#ref-gross-schafer-2011). Campaigns to rescind the prize have not succeeded, but the debate itself marks how completely the field's founding achievement was reassessed.

That reassessment left a lasting suspicion of any surgery for mental illness, and it shaped the regulatory environment in which the modern field operates. Contemporary psychosurgery is hedged with safeguards the lobotomy never had — multidisciplinary review, informed consent, reserved use for the most severe and treatment-resistant cases, and formal outcome measurement — precisely because the discipline is defined against its own history (#ref-feldman-goodrich-2001).

Modern Stereotactic Psychosurgery

The psychosurgery that survived is stereotactic: it uses a three-dimensional coordinate frame and brain imaging to place a small, precisely located lesion, rather than the broad freehand cuts of the lobotomy. A handful of ablative procedures are still performed for the most severe and otherwise untreatable cases of obsessive-compulsive disorder and depression. Anterior capsulotomy places bilateral lesions in the anterior limb of the internal capsule to interrupt frontal-subcortical circuits; a long-term follow-up of patients treated for OCD found meaningful symptom reduction in a substantial fraction, though at the cost of adverse effects in some (#ref-ruck-2008). Cingulotomy, a lesion of the anterior cingulate, is the other principal ablative target (#ref-mashour-2005).

The move from the lobotomy to modern psychosurgery was not a single step but a change on two axes at once: how much tissue the procedure affects, and how precisely it is targeted. Step through the eras and read both bars.

Schematic values illustrating the trend, not measured lesion volumes: tissue affected falls and targeting precision rises across the eras, and only the final step adds reversibility. Computed locally, nothing stored.

The demo above sets the crude and modern procedures side by side along the timeline, so the change in character can be read directly: the lobotomy destroyed large volumes of frontal white matter freehand, whereas a stereotactic capsulotomy places a lesion of a few millimetres at imaged coordinates. What separates modern ablative psychosurgery from the lobotomy is not that it destroys tissue — it does — but the scale, the targeting, and the governance around it. The lesion is small, its location is chosen from a circuit model rather than a lobe-wide theory, and the decision to make it passes through review and consent that the lobotomy bypassed entirely (#ref-feldman-goodrich-2001).

Even so, an ablative lesion is permanent, and that permanence is the ethical pressure that drove the field toward a reversible alternative. If the same circuits could be modulated rather than destroyed, the central objection to psychosurgery — that a mistake cannot be undone — would be answered. That is the promise that deep brain stimulation was developed to deliver (#ref-nuttin-1999).

Deep Brain Stimulation

Deep brain stimulation (DBS) implants electrodes in a targeted structure and delivers continuous high-frequency current from an implanted pulse generator, modulating the activity of a circuit without destroying it. Because the stimulation can be adjusted or switched off, DBS is reversible in a way no ablative procedure is, and this is the property that revived surgical treatment of psychiatric illness. In 1999 Bart Nuttin and colleagues reported the first use of DBS for OCD, stimulating the anterior limb of the internal capsule — the same target as capsulotomy — and observing benefit in patients who had exhausted other treatment (#ref-nuttin-1999).

The OCD work expanded into a multi-centre programme targeting the ventral capsule/ventral striatum. A collaborative report pooling the worldwide experience found that a substantial proportion of patients with severe, treatment-refractory OCD achieved a clinically meaningful response, sustained over years of follow-up, and this evidence supported a humanitarian device exemption for the indication (#ref-greenberg-2010). In parallel, Helen Mayberg and colleagues extended DBS to depression: reasoning from imaging that the subcallosal cingulate (Brodmann area 25) was metabolically overactive in treatment-resistant depression, they stimulated it directly and reported antidepressant response in patients who had failed medication, psychotherapy, and electroconvulsive therapy (#ref-mayberg-2005).

Table 1 sets out the principal modern targets, the disorder each addresses, whether the intervention is ablative or stimulating, and the study that established it. The pattern is a small set of circuit nodes, approached either by a permanent lesion or by reversible stimulation, for a small population of the most severely and persistently ill.

Modern psychosurgery works on a small set of circuit nodes, each approached either by a permanent lesion or by reversible stimulation. Select a target to see the disorder it addresses, the modality, and the study that established it.

Schematic coronal section; target positions are indicative, not stereotactic coordinates. Targets and establishing studies match Table 1. Two targets share the anterior limb of the internal capsule — one stimulated, one lesioned — which is the clearest illustration of the modality choice. Computed locally, nothing stored.

The demo above lets each modern target be selected on a schematic of the brain, showing the disorder it addresses and whether it is approached by lesion or by stimulation. The clinical logic is the same across targets: identify a node in a dysfunctional circuit, and either interrupt it permanently or drive it reversibly. The reversibility of stimulation is the central advance, but it comes at the cost of hardware, ongoing programming, and the surgical risks of an implant — trade-offs the ablative procedures avoid at the price of permanence (#ref-greenberg-2010).

Worked Example

The modern trials measure benefit with a validated symptom scale rather than the operators' impressions that justified the lobotomy, and the definition of a treatment response is a fixed arithmetic threshold on that scale. For OCD the standard instrument is the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), scored from 0 to 40, and the conventional definition of a response in the DBS trials is a reduction of at least 35 percent from the patient's baseline score (#ref-greenberg-2010).

Modern trials define a treatment response as a fixed percentage fall on a validated scale. For OCD the scale is the Yale-Brown Obsessive Compulsive Scale (0–40), and a response is a reduction of at least 35% from baseline. Set a baseline and a follow-up score and apply the rule.

With the default 34 → 20, the reduction is 14 points and 41.2% — the case worked through in the text, a responder. Drop the follow-up only to 23 and the same patient (32.4%) becomes a non-response: the responder rate a trial reports depends on where the line is drawn. Computed locally, nothing stored.

Suppose a patient enters a trial with a baseline Y-BOCS of 34 — severe, incapacitating symptoms — and after stimulation the score falls to 20. The absolute reduction is

34 − 20 = 14 points.

Expressed as a fraction of the baseline, the percentage reduction is

14 / 34 = 0.4118 = 41.2 percent.

Because 41.2 percent exceeds the 35 percent threshold, this patient is classified a responder. The demo lets the baseline and follow-up scores be varied and applies the same rule, showing how close a case can sit to the cut-off: a fall from 34 to 23 is a 32.4 percent reduction and counts as a non-response, even though the patient improved by eleven points. Two lessons follow. First, a “response” is a dichotomised threshold on a continuous scale, so the responder rate a trial reports depends on where the line is drawn as well as on how much patients improved. Second, this explicit, pre-specified arithmetic is exactly what the lobotomy era lacked: an outcome anyone can check, replacing the operator's judgement that a patient was better (#ref-greenberg-2010).

Discussion

Psychosurgery is the branch of psychiatric treatment most shaped by its own history. The lobotomy was adopted on almost no evidence, applied at enormous scale, and honoured with a Nobel Prize, and its collapse taught medicine a lasting lesson about the danger of an irreversible treatment advanced on uncontrolled reports and professional enthusiasm (#ref-gross-schafer-2011). Every feature of the modern field — the stereotactic precision, the restriction to treatment-resistant cases, the multidisciplinary review, the reversible stimulation, the pre-specified outcome thresholds — is a deliberate answer to a specific failure of the lobotomy era (#ref-feldman-goodrich-2001).

Whether the modern procedures have escaped the deeper problem is not yet settled. The open-label and case-series evidence for DBS in OCD and depression is genuinely encouraging, and for the most severely ill it offers a possibility where nothing else remains. But open-label results are the same kind of evidence that misled the field before, vulnerable to selection and to the expectations of patients and clinicians alike, and the history of psychosurgery is a warning against trusting them too far (#ref-mashour-2005). The reversibility of stimulation lowers the stakes of being wrong, but it does not by itself establish that the treatment works.

The honest position is that modern psychosurgery is a small, carefully governed practice with a provisional evidence base, offered to a population for whom the alternative is intractable suffering. It is neither the barbarism its history suggests nor a settled therapy, and holding both of those facts at once — the real promise and the unproven status — is what the discipline's past demands of it.

Current Directions

The central recent development is the collision between DBS's promising open-label results and the controlled trials designed to test them. When subcallosal cingulate DBS for depression was submitted to a multi-site, randomised, sham-controlled trial — the design that holds patient and clinician expectation constant — the trial was halted early for futility, finding no significant difference between active and sham stimulation over its blinded phase (#ref-holtzheimer-2017). This negative result stands in sharp tension with the encouraging open-label reports, and it is the single most important piece of evidence in the modern field precisely because it is the kind of test the lobotomy era never applied.

The picture is not uniformly discouraging. A long-term open-label follow-up of subcallosal cingulate DBS reported that response and remission rates rose over several years of continued stimulation and were largely maintained, suggesting that the benefit may emerge on a timescale a short blinded phase cannot capture (#ref-crowell-2019). The reconciliation of these findings — a negative controlled trial against sustained open-label improvement — turns on questions of stimulation target, patient selection, individualised connectomic targeting, and the timescale over which an antidepressant effect develops, all of which are active areas of investigation. For OCD, a meta-analytic comparison of the two surgical approaches found that ablative neurosurgery and DBS produced broadly comparable symptom reduction, sharpening the practical question of when a reversible implant justifies its added cost and risk over a permanent lesion (#ref-kumar-2019).

Common Misconceptions

Psychosurgery is a thing of the past that is no longer performed.

Stereotactic ablative procedures and deep brain stimulation are performed today at specialised centres for severe, treatment-resistant OCD and depression, under review and consent safeguards the lobotomy never had (#ref-mashour-2005).

The lobotomy and modern psychosurgery are essentially the same thing.

They share only a lineage. The lobotomy destroyed large volumes of frontal white matter freehand on a lobe-wide theory; modern procedures place millimetre lesions or reversible electrodes at imaged circuit targets, and reserve them for the most refractory cases (#ref-feldman-goodrich-2001).

Moniz's Nobel Prize proves the lobotomy worked.

The 1949 prize was awarded on uncontrolled reports and advocacy during a wave of enthusiasm; later historical and ethical analysis judged the honour to have legitimised a harmful procedure, and it remains one of the prize's most contested awards (#ref-gross-schafer-2011).

Deep brain stimulation destroys brain tissue like a lobotomy.

Deep brain stimulation implants electrodes that modulate a circuit with electrical current and can be adjusted or switched off; it is reversible neuromodulation, not the permanent tissue destruction of an ablative procedure (#ref-nuttin-1999).

Glossary

Ablation.

The deliberate destruction of a small volume of brain tissue to interrupt a circuit; the permanent, irreversible mode of psychosurgery, contrasted with stimulation.

Anterior capsulotomy.

A stereotactic ablative lesion placed bilaterally in the anterior limb of the internal capsule to interrupt frontal-subcortical circuits, used for severe treatment-resistant OCD.

Cingulotomy.

A stereotactic ablative lesion of the anterior cingulate cortex, one of the principal ablative targets in modern psychosurgery.

Deep brain stimulation.

The implantation of electrodes delivering continuous current to a targeted structure, modulating a circuit reversibly rather than destroying it; the principal modern psychosurgical modality.

Electroconvulsive therapy.

A non-surgical somatic treatment inducing a therapeutic seizure under anaesthesia; a comparator and, when it fails, a gateway to surgical treatment of depression.

Internal capsule.

A band of white matter carrying fibres between the cortex and deeper structures; its anterior limb is a shared target of capsulotomy and OCD deep brain stimulation.

Leucotomy.

Moniz's original operation severing the white-matter tracts of the prefrontal cortex; also spelled leukotomy, and the direct ancestor of the lobotomy.

Lobotomy.

The crude surgical disconnection of the frontal lobes practised from the 1930s to the 1950s; the procedure whose harms made psychosurgery a byword for medical overreach.

Neuromodulation.

The alteration of neural activity by a reversible external influence such as electrical stimulation, as opposed to the permanent alteration of an ablative lesion.

Prefrontal cortex.

The anterior frontal region governing planning, judgement, and emotional regulation; the target of the leucotomy and lobotomy, whose disconnection produced their characteristic blunting.

Psychosurgery.

The treatment of a psychiatric disorder by an operation that deliberately alters brain tissue or its activity, targeting the substrate of a symptom rather than a structural lesion.

Sham control.

In a stimulation trial, an implanted but inactive condition indistinguishable to patient and rater, isolating the treatment's specific effect from expectation; the design that returned a negative result for depression DBS.

Stereotactic surgery.

Surgery guided by a three-dimensional coordinate frame and imaging to reach a precise internal target; the technical basis that distinguishes modern psychosurgery from the freehand lobotomy.

Subcallosal cingulate.

A region of the cingulate cortex (Brodmann area 25) overactive in treatment-resistant depression, the target of Mayberg's deep brain stimulation for the condition.

Transorbital lobotomy.

Freeman's rapid technique reaching the frontal lobes through the bony orbit above the eye, which made the lobotomy fast and portable and drove its mass application.

Yale-Brown Obsessive Compulsive Scale.

The standard 0–40 symptom instrument for OCD (Y-BOCS); a reduction of at least 35 percent from baseline is the conventional definition of a treatment response.

Key Researchers

Walter Jackson Freeman (1895–1972). American neurologist who popularised the prefrontal lobotomy in the United States and developed the transorbital technique, performing or supervising thousands of operations; the central and most controversial figure of the lobotomy era. Wikipedia - Wikidata

Benjamin D. Greenberg (living). Psychiatrist at Brown University and Butler Hospital who led the worldwide study of ventral capsule/ventral striatum deep brain stimulation for obsessive-compulsive disorder. Faculty Page - Google Scholar

Helen S. Mayberg (living). Neurologist who pioneered subcallosal cingulate deep brain stimulation for treatment-resistant depression and directs the Nash Family Center for Advanced Circuit Therapeutics at Mount Sinai. ORCID - Wikipedia

António Egas Moniz (1874–1955). Portuguese neurologist who introduced the prefrontal leucotomy in 1935 and received the 1949 Nobel Prize in Physiology or Medicine for it; the founder of modern psychosurgery and the focus of its ethical reassessment. Wikipedia - Wikidata

Bart Nuttin (living). Belgian neurosurgeon who performed the first deep brain stimulation for obsessive-compulsive disorder in 1999 and co-led its later multicentre evaluation; emeritus professor of experimental neurosurgery at KU Leuven. ORCID - Faculty Page

Christian Rück (living). Psychiatrist at Karolinska Institutet who published the long-term follow-up of anterior capsulotomy for OCD and studies ablative and non-ablative surgical treatment of the disorder. ORCID - Wikidata

Frequently Asked Questions

What is psychosurgery? It is the treatment of a psychiatric disorder by an operation that deliberately alters brain tissue or its activity, aimed at the neural substrate of a mental symptom rather than at a structural lesion such as a tumour. In MeSH it is descriptor D011612 (Feldman & Goodrich, 2001).

Who invented the lobotomy? The Portuguese neurologist António Egas Moniz performed the first prefrontal leucotomy in 1935, and the American neurologist Walter Freeman developed and mass-popularised the lobotomy in the United States, including the transorbital technique (Tan & Yip, 2014).

Why was Egas Moniz awarded the Nobel Prize? He received the 1949 Nobel Prize in Physiology or Medicine for the prefrontal leucotomy, during a period of enthusiasm for the operation; later historical analysis has argued the award was granted on weak, uncontrolled evidence and remains deeply contested (Gross & Schäfer, 2011).

Is psychosurgery still performed today? Yes, but narrowly. Stereotactic ablative procedures and deep brain stimulation are offered at specialised centres for the most severe, treatment-resistant OCD and depression, under safeguards the lobotomy era lacked (Mashour et al., 2005).

What is the difference between a lobotomy and deep brain stimulation? A lobotomy permanently destroyed large volumes of frontal white matter; deep brain stimulation implants electrodes that modulate a small, imaged circuit target with current and can be adjusted or switched off, making it reversible (Nuttin et al., 1999).

What conditions is modern psychosurgery used for? Chiefly treatment-resistant obsessive-compulsive disorder and treatment-resistant depression, in patients who have not responded to medication, psychotherapy, and other somatic treatments (Greenberg et al., 2010).

How effective is deep brain stimulation for OCD and depression? Open-label studies report meaningful benefit in a substantial fraction of severely ill patients, but a randomised sham-controlled trial of depression stimulation was negative, so the controlled evidence remains provisional (Holtzheimer et al., 2017).

Is deep brain stimulation reversible? Yes. Unlike an ablative lesion, the electrodes can be reprogrammed or turned off, and this reversibility is the main reason surgical treatment of psychiatric illness was revived after the lobotomy era (Nuttin et al., 1999).

References